{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:20:38Z","timestamp":1761895238217},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1097\/iae.0b013e3181ff9546","type":"journal-article","created":{"date-parts":[[2011,2,25]],"date-time":"2011-02-25T08:29:30Z","timestamp":1298622570000},"page":"1089-1094","source":"Crossref","is-referenced-by-count":17,"title":["PHOTODYNAMIC THERAPY IN HIGHLY MYOPIC EYES WITH CHOROIDAL NEOVASCULARIZATION"],"prefix":"10.1097","volume":"31","author":[{"given":"Andr\u00e9 M","family":"Coutinho","sequence":"first","affiliation":[]},{"given":"Rufino M","family":"Silva","sequence":"additional","affiliation":[]},{"given":"Sandrina G","family":"Nunes","sequence":"additional","affiliation":[]},{"given":"Maria L","family":"Cachulo","sequence":"additional","affiliation":[]},{"given":"Jo\u00e3o P","family":"Figueira","sequence":"additional","affiliation":[]},{"given":"Joaquim N","family":"Murta","sequence":"additional","affiliation":[]}],"member":"276","reference":[{"key":"R1-11-20210130","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S0161-6420(01)00544-9","article-title":"Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin: 1-year results of a randomized clinical trialVIP report no. 1.","volume":"108","year":"2001","journal-title":"Ophthalmology"},{"key":"R2-11-20210130","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1136\/bjo.2006.099887","article-title":"Intravitreal injection of bevacizumab for choroidal neovascularisation associated with pathologic myopia.","volume":"91","author":"Sakaguchi","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"R3-11-20210130","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1097\/IAE.0b013e31817eda41","article-title":"Short-term efficacy and safety of intravitreal ranibizumab for myopic choroidal neovascularization.","volume":"28","author":"Silva","year":"2008","journal-title":"Retina"},{"key":"R4-11-20210130","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1016\/j.ophtha.2007.03.043","article-title":"Intravitreal bevacizumab (Avastin) for myopic choroidal neovascularisation: six-month results of a prospective pilot study.","volume":"114","author":"Chan","year":"2007","journal-title":"Ophthalmology"},{"key":"R5-11-20210130","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0161-6420(02)01998-X","article-title":"Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trialVIP report no. 3.","volume":"110","year":"2003","journal-title":"Ophthalmology"},{"key":"R6-11-20210130","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/IAE.0b013e3181c9691e","article-title":"Intravitreal ranibizumab for myopic choroidal neovascularization: 12 month results.","volume":"30","author":"Silva","year":"2010","journal-title":"Retina"},{"key":"R7-11-20210130","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1136\/bjo.2007.132795","article-title":"Photodynamic therapy to treat choroidal neovacularisation in highly myopic patients: 4 years outcome.","volume":"92","author":"Ruiz-Moreno","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"R8-11-20210130","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.ajo.2004.04.055","article-title":"Prognostic factors influencing visual outcome of photodynamic therapy for subfoveal choroidal neovascularisation in pathologic myopia.","volume":"138","author":"Ergun","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"R9-11-20210130","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.ajo.2004.05.074","article-title":"Photodynamic therapy of subfoveal choroidal neovascularisation in high myopia in a clinical setting: visual outcome in relation to age at treatment.","volume":"138","author":"Axer-Siegel","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"R10-11-20210130","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1136\/bjo.87.2.173","article-title":"Verteporfin photodynamic therapy in highly myopic subfoveal choroidal neovascularisation.","volume":"87","author":"Montero","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"R11-11-20210130","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.ajo.2009.03.026","article-title":"Comparison of visual outcome and regression pattern of myopic choroidal neovascularisation after intravitreal bevacizumab or after photodynamic therapy.","volume":"148","author":"Hayashi","year":"2009","journal-title":"Am J Ophthalmol"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0b013e3181ff9546","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T00:42:15Z","timestamp":1620952935000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006982-201106000-00011"}},"subtitle":["5 Years of Follow-Up"],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":11,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0b013e3181ff9546","relation":{},"ISSN":["0275-004X"],"issn-type":[{"value":"0275-004X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]}}}